Top Stories
-
With several targeted Parkinson’s disease drugs entering clinical trials, a new genetic testing and counseling program may help identify patients who qualify for enrollment.
Topic
-
Survivors of cardiac arrest are more likely to experience further heart trouble if they have symptoms of PTSD, according to a new study from researchers at Columbia University Irving Medical Center.
Topic
-
A hormone called irisin–produced during exercise–may protect neurons against Alzheimer’s disease.
Topic
-
Aerobic exercise is known to improve cognition in the elderly; a new Columbia study shows it’s good for adults as young as 20.
Topic
Latest News
- November 11, 2014
Several CUMC researchers received grants from the NIH's new BRAIN Initiative, a 12-year research program launched last year by President Obama.
Topic
- October 26, 2014
Dietary cocoa flavanols—naturally occurring bioactives found in cocoa—reversed age-related memory decline in healthy older adults, according to a study led by CUMC scientists.
Topic
- August 21, 2014
Research from David Sulzer’s lab suggests that a delay in the normal elimination of excess synapses in the brain may be a common cause of autism.
Topic
-
Source:
The New York TimesAugust 12, 2014 - July 15, 2014
NewYork-Presbyterian Hospital is No. 6 in the country and No. 1 in New York in this year's U.S. News & World Report's hospital ranking.
Topic
- July 10, 2014
Story focuses on Hip Hop Public Health’s new anti-obesity campaign, which is based on obesity research conducted at Columbia University Medical Center.
Topic
- July 7, 2014
Columbia is part of a new consortium to identify rare genetic variants that may protect against, or contribute to Alzheimer’s disease.
Topic
- June 9, 2014
A new study measures the risk of developing Parkinson's for people with Gaucher disease and Gaucher carriers.
Topic
- May 28, 2014
Columbia researchers have taken a significant step forward toward deciphering the genetics of schizophrenia, which could have important implications for early detection of the condition.
- May 21, 2014
A study of long-acting injectable antipsychotics for people with schizophrenia found that newer medication was no more effective than older, less expensive medication.
Topic
